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Besides the consensus meeting in Amersfoort in
1988 and the Bethesda conference in 1994
recommendations are not available in the Nether-
lands for screening and evaluation ofathletes with
cardiac arrhythiias.1"2
Guidelines for competitive athletes with cardiac
arrhythmias in the United States and Italy were
published in 2000.2,3 In 1998 Estes et al.4
published the most important opinions on sudden
cardiac death, screening and evaluation ofathletes
and arrhytmiias.
This study addresses the physiological and
morphological consequences of athletic training,
cardiac pathology and risk stratification for sudden
cardiac death. Recommendations for competitive
athletes with cardiovascular abnormalities,
arrhythmias and proposals for specific protocols
are given. (NetbHeartJ2004;12:157-64.)
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Cardiac adaptations and morphological
consequences of athletic performance
Increased levels in maximal oxygen intake (VO2 ma,),
increased maximal cardiac output, increased widening
ofmaximal arteriovenous oxygen content difference,
increase in stroke volume and a decrease in resting
heart rate are the physiological cardiovascular effects
of systematic training. The combination of these
features is called 'the athletic heart syndrome'.5,6
The morphological cardiovascular consequence of
systematic training in athletes is dependent on the type
and intensity ofthe training schedule, gender and age
of the athlete. The combination of isotonic and iso-
metric exercise will give a wide spectrum of cardio-
vascular adaptations.
The isotonic or dynamic stress is associated with
volume loading of the myocardium and leads to
eccentric left ventricular hypertrophy. Ventricular mass
and dimension are found to have increased in en-
durance athletes, usually by 35 to 45%. Isometric or
static stress is associated with a pressure loading ofthe
left ventricle and could lead to disproportionate
increase in wall thickness. In table 1 a summary ofthe
pure form of adaptation is given.
Table 2 shows the classification ofsports based on
isotonic and isometric components during different
sporting activities.
The ECG ofan athlete can show aberrations in a broad
spectrum. Endurance training for a long period oftime
induces changes in heart rate, conduction and repolar-
isation. The most striking changes are bradycardia and
large voltages ofthe QRS complex, suggestive ofleft
ventricular hypertrophy. As regards to the repolar-
isation pattern of an athlete's ECG, it is difficult to
differentiate between structural heart disease and a
normal heart.
In a large study by Pellicia et al.7 5% ofthe athletes
had structural heart disease and 51% ofthem had an
abnormal ECG. Forty-nine percent ofthe athletes with
structural heart disease had a normal ECG. Ofthe 952
athletes without evidence ofcardiac disease, 375 (39%)
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had an abnormal ECG and could be dassified as false-
positives.
Nontraumatic sudden death In athletes
The benefit of physical training in preventing
cardiovascular disease has been subject of many
studies.8'9 Sudden cardiac death in athletes is a rare, an
unexpected and emotional event. Sudden cardiac death
is defined here as the abrupt, unexpected death of
cardiovascular aetiology, in which there is loss of
consciousness within one hour ofonset ofsymptoms.'0
The incidence of sudden cardiac death in the
general population is three to ten cases per 10,000
subjects,4 90% of the victims are male."I In the
Netherlands the incidence is between 150 and 200
athletes/year.'2 Analysis ofpostmortem studies shows
a similar entity of cardiac diagnosis,'3 which can
precipitate sudden cardiac death in male athletes. There
is a difference in the causes ofsudden and nonsudden
death in men (including athletes) related to age. The
risk of sudden death in the group of men, including
athletes, younger than 35 is 0.5 to 1 per 100,000/year.
Males older than 35 years clearly show a higher
mortality at 1 to 2 per 1000/year.4
In the group under 35 years ofage, hypertrophic
cardiomyopathy is responsible for 40% of sudden
deaths, the second most frequent cause is a coronary
anomaly in which the coronary artery is located
between the aorta and the pulmonary artery (figure 1).
The remaining other diseases, idiopathic myocardial
hypertrophy, arrhythmogenic right ventricular dys-
plasia (ARVD), Wolff-Parkinson-White Syndrome
with a bypass tract with a short refractory period, long-
QT syndrome, myocarditis, Marfan's syndrome and
premature coronary artery disease are depicted in tables
Table 2. Classification of sports.2
Classfilcatlon of sports A.
Low lsotonic
B.
Moderate Isotonic
1. Low Isometric
I. Moderate Isometric
Ill. High Isometric
Billiards
Bowling
Cricket
Golf
Riflery
Archery
Auto racing
Diving
Equestrian
Motorcycling
Bobsledding
Gymnastics
Karate/Judo
Sailing
Rock-climbing
Water-skiing
Weight-lifting
Windsurfing
Baseball
Softball
Table tennis
Tennis doubles
Volley-ball
Soccer
Squash
Tennis singles
Fencing
Figure skating
Rugby
Running sprint
Surfing
Body building
Downhill skiing
Swimming
Wrestling
Water polo
Badminton
Cross-country skiing
Field hockey
Race walking
Running
Basketball
Ice hockey
Cross-country skating
Running middle distance
Team handball
Boxing
Canoeing/Kayaking
Cycling
Decathlon
Rowing
Speed skating
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Table 1. Physiological and morphological cardiac
adaptation to systematic training.
Isotonic loading
- Increased stroke volume and end-diastolic volume
- Increased VO2max
- Increased aerobic power (respiration) of the skeletal
muscle
- Cardiac mass-volume ratio unchanged
Isometric loading:
- Increased left ventricular mass
- No increase in V02max
- No increase in LVED
- Increase in cardiac mass-volume ratio
LVED=left ventricular end-diastolic dimension.
C.
High Isotonic
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Figure 1. Estimatedprevalence ofsudden cardiac death in athletes
younger than 35.
Figure 3. Sex- and age-specific ratesfor sudden cardiac death and
total coronary heart disease deaths.26
Figure 2. Estimated prevalence ofsudden death in athletes older
than 35.
3 and 4. In the group over 35 years of age an acute
coronary syndrome is responsible for more than 80%
of sudden cardiac deaths. Less frequent causes are
hypertrophic cardiomyopathy (HCM), dilated
cardiomyopathy (DCM), ARVD, mitral valve prolapse
(MVP) and valve disease (figure 2.)
Gender-related differences
Differences are found between men and women in
ECG, QT interval, mean heart rate and dimension of
the ventricle. The QT interval in women is more
prolonged at low heart rates than in men and this is
associated with the finding that ventricular arrhythmia,
such as torsade de pointes, is more common inwomen.
The highest quartile ofthe prolonged QTc interval in
women is associated with an increased risk factor for
cardiac mortality.'4 A 26-year follow-up in the
Table 4. Cardiac and noncardiac causes of sudden cardiac
death.'7
Cardiac causes
HCM
CAD
ARVD
CM
LVH
Myocarditis
Conduction disorder
Mitral valve prolapse
Valve disease
Aorta dissection
Noncardiac causes?
Arteriovenous anomaly
WPW
Myocardial bridging
Coronary aneurysm
Subvalvular aortic stenoses
LQTS
Idiopathic VF
DCM
Cerebral embolus
Pulmonary embolus
HCM=hypertrophic cardiomyopathy, CAD=coronary artery disease,
ARVD=arrhythmic right ventricular cardiomyopathy, CAA=congenital coronary
artery anomalies, LVH=left ventricular hypertrophy, WPW=Wolff-Parkinson-
White syndrome, LQTS=long-QT syndrome, VF=ventricular fibillation,
DCM=dilated cardiopathy.
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Cardiac hypertrophy
M 10%Coronary anomalies
19%i Ruptured aorta
5%
Tunnelled LAD
5%
Aortic stenosis
4%
Myocarditis 3%
DCM 3%
ARVD 3%
MVP 2%
CAD 2%
Coronary artery disease
84% _
HCM 4%
MVP 4%
Valvular disease 4%
Unexplained 4%
30 - - 7
Male
t25 ---- Female Total death
~~~~~~~~~~~~5
20-
~~~~~~~~~~4
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i 10-/_'Sudden death
oGa--f C---""' -2
10 2
35-44 45-54 55-64 65-74 75-84 35-84
Age (in years)
Table 3. Prevalence of cardiovascular disease and risk for
sudden death in the UK.18
Diagnosis Prevalence Persons at rdsk
HCM 20:10,000 100,000
ARVD 1:10,000 5000
WPW 15:10,000 75,000
LQTS 1:10,000 5000
CM 20:10,000 100,000
MVP 200:10,000 1,000,000
Marfan 2:10,000 10,000
HCM=hypertrophic cardiomyopathy, ARVD=arrhythmogenic right ventricular
cardiomyopathy, WPW=Woff-Parkinson-White syndrome, LQTS=long4QT syn-
drome, CAA=congenital coronary artery anomaly, MVP=mitral valve prolapse.
159
Recommendations and cardiological evaluation of athletes with arrhythmias
Framingham study shows a clear difference in sudden
cardiac death between men and women (figure 3).
Screening athletes at risk of sudden cardiac death
In general it is not advisable to screen large groups of
asymptomatic athletes because of the very low in-
cidence of sudden cardiac death. Epstein et al.'5
estimated the value ofscreening: to identify ten athletes
with a significant risk ofSCD, 200,000 subjects had
to be screened under the age of30. One out ofthese,
ten subjects at risk will actually suffer SCD.
Nevertheless, several investigators are ofthe opinion
that one could identify subjects at risk with a com-
bination ofappropriate history and physical examination
focused on the major diseases mentioned in figure 1
and table 4 13,15-17
Sharma et al.18 published a summary ofthe incidence
and prevalence of athletes risking SCD (table 3) and
made suggestions for identifying subjects at risk,
screening and proper diagnosis.
Prominent cardiac disorders provoking sudden
death in competitive sport
1. Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy is a primary heart
muscle disorder with autosomal dominant inheritance,'9
with a prevalence of2:1000 in the general population.
Sudden death is sometimes the first symptom of the
disease and the causes are atrial arrhythmias and
ventricular tachycardias provoked by exercise. Athletes
with HCM run a higher risk of sudden death than
non-athletes.20
Specific medical history can include young sudden
death victims in the family, exertion-related dyspnoea,
light-headedness during or shortly after exertion,
history ofsyncope, chest discomfort, palpitations and
early fatigue. Abnormalities in physical examination
are abnormal jugular venous wave, prominent carotid
pulse in case ofoutflow obstruction. The examination
of the athlete should be conducted sitting up and
Netherlands Heart Journal, Volume 12, Number 4, April 2004
Table 5. Diagnostic criteria for right ventricular dysplasia.11
1. Global and/or reglonal dysfunction and structural alterations
Major:
- Severe dilatation and reduction of RV ejection fraction with no (or only mild) LV impairment
- Localised RV aneurysms (akinetic or dyskinetic areas with diastolic bulging)
- Severe segmental dilatation of the RV
Minor:
- Mild global RV dilatation and/or ejection fraction reduction with normal LV
- Mild segmental dilatation of the RV
- Regional RV hypokinesia
II. Endomyocardial biopsy flndings
Major:
- Fibro-fatty replacement of myocardium
Ili. Repolarisation abnormalities
Minor:
- Inverted T waves in right precordial leads (V2 and V3) (if more than 12 years and no right bundle branch block)
IV. Depolarisation/conduction abnormalities
Major:
- Epsilon waves or localised prolongation (>110 ms) of the QRS complex in right precordial leads (V,7V3)
Minor:
- Late potentials on signal-averaged ECG
V. Arrhythmias
Minor:
- Left bundle branch block type sustained or nonsustained VT on ECG, Holter or exercise testing
- Frequent ventricular extra systoles (more than 1000/24 hours)
VI. Family history
Major:
- Familial disease confirmed at autopsy or surgery
Minor:
- Familial history of premature sudden death (<35 years) due to suspected right ventricular dysplasia
- Familial history (clinical diagnosis based on present criteria)
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standing, with auscultation of the systolic ejection
murmur during Vasalva and squatting.
Diagnosis is based on family history, symptoms,
physical examination, ECG, Doppler echocardiog-
raphy and genetic counselling.
Recommendation
Athletes with an unequivocal diagnosis ofhypertrophic
cardiomyopathy should not participate in most
competitive sports with the possible exception of low-
intensity ones (class 1A). This recommendation in-
cludes all athletes with or without symptoms of left
ventricular outflow obstruction.
Exclusion criteria are athletes older than 35 years
with low-risk factors for sudden death, including
absence of ventricular arrhythmias, family history of
sudden death, history of syncope or near syncope,
outflow tract obstruction less than 50 mmHg,
exercised-induced hypotension, moderate to severe
mitral regurgitation, enlargement of the left atrium,
paroxysmal atrial fibrillation and myocardial perfusion
defects.
There should be no participation in competitive
sport except for low intensity class IA sport.2
2. Arrhythmogenic right ventricular dysplasia
ARVD is a primary heart muscle disorder often
associated with autosomal dominant inheritance.2' 27
It is characterised by fibro-fatty atrophy of the right
ventricular myocardium and in some cases of the left
ventricle as well. Prevalence is 1:10,000 in the general
population, but may be higher because ofasymptom-
atic or less symptomatic individuals. The cause of
sudden death is ventricular tachycardia and ventricular
fibrillation. The fibro-fatty infiltration in the myo-
cardium is considered the mechanism for a re-entry
tachycardia.
Specific medical history consists of palpitations
during mental or physical stress, syncope and/or chest
pain during exertion and family history of sudden
cardiac death. Physical examination is not informative.
For the diagnostics see table 5. Myocardial biopsies can
sometimes give a false-negative result. Therapy options
forARVD are ,-blocker including sotalol, ablation and
implantable cardioverter defibrillator (ICD).
Recommendation
See HCM.
3. Congenital coronary artery anomalies
The prevalence is probably 2:1000 in the general
population.28 29 The left main coronary artery originates
from the right sinus of Vasalva. The left main passes
between the aorta and the pulmonary artery; this results
in a slit-like orifice. During exertion the coronary artery
is compressed between the aorta and pulmonary artery
as a result of the increase in their diameter produced
by an increase in cardiac output. Excessive torsion of
the coronary artery during exercise may exaggerate the
slit-like orifice to be obstructed. The resulting ischaemia
is the cause ofventricular arrhythmias. Specific medical
history is syncope and/or chest pain during exertion,
with dyspnoea disproportional to the amount of
exertion. Physical examination is not informative. ECG
and nuclear stress testing can be normal but echo-
cardiography, transoesophageal echocardiography,MR
imaging, computed tomography (CT) and coronary
angiogram could be informative. Therapy involves
coronary bypass grafting or re-implantation of the
coronary arteries.
Recommendation
Detection of these abnormalities should result in
exclusion from all competitive sports. Participation in
sports >6 months after surgical correction for indi-
viduals without exercised induced ischaemia is per-
mitted.
4a. Premature atherosclerotic coronary artery
disease
Prevalence is 4 to 9% in competitive athletes. Sudden
death results from a ruptured plaque in a coronary
artery. Almost all victims have one-vessel disease with
fewer than 50% atherosclerotic lesions.'3'30 There are
seldom pre-event symptoms, but there can be a family
history ofmanifestations ofpremature coronary artery
disease and/or hypercholesterolaemia. Physical exam-
ination is not informative. The ECG is normal at rest,
diagnosis can be made by exercise ECG or nuclear
stress testing, echocardiography, radionuclide angio-
graphy or left ventricular angiography to assess left
ventricular function. Therapy options are 5-blockers,
calcium antagonists, nitrates, antiplatelet drugs and
treatment of cardiovascular risk factors. Smoking and
cocaine use should be suspended.
4b. Atherosclerotic coronary artery disease,
coronary artery disease, post-coronary bypass graft
surgery and post-percutaneous transluminal
coronary angioplasty with or without stent
Coronary artery disease is the most frequent cause of
exercise-induced sudden cardiac death in adults. The
incidence of myocardial infarction, sudden death and
cardiac arrest increases with vigorous physical activity.
Possible mechanisms include plaque rupture, coronary
spasm, decreased coronary flow reserve, catecholamine-
induced platelet aggregation, hypertension and in-
creasing shear forces in the coronary artery. Physicians
should be aware that athletes may minimise symptoms
and that cardiac discomfort is not always classical angina
but tightness, heartburn, exercise intolerance, unusual
dyspnoea or exercise syncope could be prodromal
cardiac symptoms. Physical examination is not in-
formative. ECG and exercise ECG or nuclear stress
testing could be normal. Echocardiography, radio-
nucide angiography or coronary angiography and left
ventricular angiography are used to assess left ventricu-
lar function. Therapy involves 5-blockers, calcium
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antagonists, nitrates, antiplatelet drugs and treatment
ofcardiovascular risk factors. Smoking and cocaine use
should be stopped.
Recommendation
Two risk levels are defined.
A. Mildly increased risk
1. Normal or nearly normal resting left ventricular
function;
2. Normal exercise tolerance for age. V02 max:
>35 mil/kg/min <50 years
>31 ml/kg/min 50-59 years
>28 ml/kg/min 60-69 years
>24 ml/kg/min >70 years
3. Absence ofexercise-induced ischaemia;
4. Absence of exercise-induced complex ventricular
arrhythmias;
5. Absence of haemodynamically significant stenosis
in all major coronary arteries.
B. Substantially increased risk
1. Impaired left ventricular systolic function at rest (EF
<50%);
2. Evidence of exercised-induced ischaemia;
3. Evidence ofexercised-induced complex ventricular
arrhythmias;
4. Haemodynamically significant stenosis in a major
coronary artery.
Athletes with mildly increased risk can participate in class
IA and IIA sports but should avoid intensely competi-
tive situations. Athletes should be examined annually.
Athletes with substantially increased risk are generally
restricted to class IA sports. Athletes should be
examined every six months.2
5. Wolff-Parkinson-White syndrome
Prevalence is 1.5:1000 in the general population with
a male/female ratio of 2:1.31 There is a high risk of
atrial fibrillation followed by ventricular fibrillation if
there is a short refractory period of the accessory
pathway. Atrial fibrillation with minimal RR intervals
<250 ms at rest or during exercise indicates an
atrioventricular bypass tract with a very short refractory
period and is a high risk factor for VF and sudden
death. Specific medical history involves unexplained
palpitations, presyncope and syncope. Physical
examination is not informative. The ECG at rest is in
sinus rhythm with a short PR interval and delta wave.
If the delta wave disappears with a procainamide
infusion or during exercise there is a low risk for
malignant ventricular arrhythmias. If the delta wave
persists during exercise or in cases of doubt about
disappearance ofthe delta wave, there is an indication
for further electrophysiological study. Therapy involves
RF catheter ablation.
Recommendation
Athletes without structural heart disease, a history of
palpitations, or without tachycardia may participate in
all competitive sports. For athletes with tachycardias,
the recommendations for supraventricular tachycardia
apply. Athletes with episodes ofatrial fibrillation whose
maximal ventricular rate at rest (without therapy) due
to conduction over the accessory pathway is <250
beats/min andwho have no episodes ofsyncope or near
syncope and have no structural heart disease appear to
be at low risk for SCD and may participate in all
competitive sports. Athletes with syncope or near
syncope or episodes ofatrial flutter or atrial fibrillation
whose maximal ventricular rate at rest due to con-
duction over the accessory pathway exceeds 250
beats/min should be scheduled for ablation and are
restricted to class IA sports.
Athletes without symptoms after a successful ablative
therapy and with no recurrence ofthe tachycardia for
three to six months have no restrictions for competitive
sports.2
6. Long-QT syndrome (LQTS)
Prevalence in the general population is 1:5000.32 There
are two rare hereditary disorders with QTc >440 ms.
The two clinical phenotypes are the autosomal dominant
form, the Romano-Ward syndrome, and the autosomal
recessive form, the Jervell and Lange-Nielsen syndrome.
Seven genotypes are identified in patients with genetic
long QTS, LQT1-7. Type I and II account for more
than 90% of the cases. Type I is present in children
(40% have symptoms before puberty) and its behaviour
Netherlands Heart Journal, Volume 12, Number 4, April 2004
Table 6. Drugs and QT prolongation.
Cardiac Quinidine, procainamide, disopyramide, sotalol, amiodarone, lidoflazine, mexitilene,
flecainide, aprindine, bepredil, dofetilide, propafenone
Antibiotics Ampicillin, erythromycin, trimethoprim, pentamidine, doxyrubicin, ketoconazole,
clarithromycin
Antihistaminic HI-receptor antagonism Prenyamine, astemizole, terfenadine, dyphenhydramine, ebastine, hydroxyzine
Antimalaria drugs Chloroquine, hydroxychloroquine
Serotonin inhibitors Fluoxetine, zimeldine, ketanserine
Other drugs Tricyclic and tetracyclic antidepressant drugs, fenothiazines, chlorahydrate,
terodiline, probucol, indoramine, cisapride, cocaine
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Table 7. Classification of hypertension.2
Adolescent 13-15 years
Systole
Diastole
Mild stage 1
135-139
85-89
Moderate stage 2
140-149
90-94
Severe stage 3 Very severe stage 4
150-159
95-99
>160
>100
Adolescent 16-18 years
Systole
Diastole
Adult >18 years
Systole
Diastole
is extremely malignant during exercise. Type II starts
at adolescence and in some cases is the first
manifestation ofSCD at a more advanced age. Some
drugs can induce a prolonged QT interval (table 6).
The trigger for SCD is torsade de pointes which
deteriorates into ventricular fibrillation. The specific
medical history involves syncope due to polymorphic
ventricular tachycardia and ventricular fibrillation,
palpitations, chest complaints and family history.
Physical exanination is not informative. TheECG shows
a prolonged QT interval, 'double hump' in the
precordial leads and morphologically abnormalT waves.
Defects in chromosome 3, 7 and 11 have specific QT
configurations. Echocardiography is normal. The
negative Holter monitoring and a negative exercise
testing could provide false-negative information. An
implantible loop recorder can help to the final diagnosis.
Therapy options are 5-blocker, pacing or ICD.
Recommendation
There is a restriction for all competitive sports.2
7. Myocarditis
The variability in the incidence of myocarditis differs
from 1 to 10% in literature.33 The clinical course in
myocarditis is unpredictable. Myocarditis can cause
arrhythmias and electrocardiographic changes in
athletes. Exercise may predispose to an adverse out-
come and could result in sudden cardiac death in the
athlete. Specific medical history can include aspecific
common cold complaints, light fever, tachycardia and
sometimes cardiomegaly. Physical examination reveals
a pulsus altemans, gallop and serious left ventricular
dysfunction. The ECG shows aspecific repolarisation
abnormalities. Abnormal left ventricular function is
seen on Doppler.
Recommendations
Restriction from all competitive sports for the 'fever
period'. A six-month period is recommended until full
convalescence. Athletes with pericarditis are treated
according to the same recommendation.2
8. Marfan's syndrome
The prevalence of Marfan's syndrome is 1:5000 in
the general population.20 34Aortic root dilatation pre-
disposes to aortic dissection and rupture resulting in
cardiac tamponade and SCD. The medical history is
aspecific; family history is positive for Marfan's syn-
drome. Physical examination reveals ocular mani-
festations (ectopia lentis) and skeletal abnormalities
consisting of dolichostenomalia and shoulder
luxations. Diagnostic options are Doppler echo-
cardiography, MRimaging and CT scan. In the case
ofaorta root dilation of>6mm prophylactic operation
is indicated.35-37
Recommendation
Athletes without a family history ofpremature SCD and
without evidence of aortic root dilatation or mitral
regurgitation may participate in class IA and IIA sports.
Echocardiography should be repeated every six
months. Athletes with aortic root dilatation may only
participate in class IA sports. Athletes with Marfan's
syndrome should not participate in sport with a risk
of bodily collision.2
9. Mitral valve prolapse (MVP)
Prevalence is 1: 50, one million people in the UKand
15 million in the US.38 The medical history is aspecific,
90% of the patients with MVP are asymptomatic
and 10% have a variable symptomatology. MVP is
sometimes associated with WPW and LQTS and
Marfan's syndrome. Physical examination reveals
the presence ofmid-systolic click and a late systolic
murmur. Doppler echocardiography is used for
diagnosis.
Recommendation
In the absence ofsymptoms and history ofsyncope
or positive family history of SCD and repetitive
forms of (exercised induced) sustained or non-
sustained supraventricular or complex ventricular
arrhythmias, there is no restriction for competitive
sport exists.2
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140-149
90-94
140-159
90-99
150-159
95-99
160-179
100-109
160-179
100-109
180-209
110-119
>180
>110
>210
>120
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10. Hypertension
Hypertension is a risk factor for SCD and ventricular
arrhythmia but there is no relation with SCD in young
athletes. In 95% of all cases the diagnosis is essential
hypertension. Not only the measurement ofthe blood
pressure at rest is important but the dynamic course
of the blood pressure during sport-specific exercise
has to be recorded as well. Marked increase in systolic
blood pressure during exercise (>240 mmHg) is
associated with an increased risk ofSCD and complex
ventricular arrhythmias.39 For the recommendations
no distinction is made between primary or secondary
hypertension. For classification ofthe hypertension by
age see table 7.
Recommendation
Athletes with mild and moderate hypertension have
no restriction for competitive sport. Athletes with stage
3 and 4 are restricted from class IIIA, IIIB and class
IIIC sports.2 N
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